Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CorMedix Inc (NYSE MKT LLC:CRMD)

1.58
Delayed Data
As of Aug 25
 -0.03 / -1.86%
Today’s Change
1.15
Today|||52-Week Range
4.54
-22.17%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$61.7M

Company Description

CorMedix, Inc. operates as pharmaceutical and medical device company that seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Bridgewater, NJ.

Contact Information

CorMedix, Inc.
1430 US Highway 206
Bridgewater New Jersey 07921
P:(908) 517-9500
Investor Relations:
(908) 517-9489

Employees

Shareholders

Individual stakeholders7.85%
Mutual fund holders5.46%
Other institutional10.65%

Top Executives

Randy D. MilbyCEO, Director & Head-Investor Relations
James R. AltlandChief Financial Officer
Antony E. PfaffleSecretary, Chief Scientific Officer & Director
John L. ArmstrongExecutive Vice President-Technical Operations
John OrtizVP-Regulatory Affairs & Quality Assurance